Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Trends in Biochemical Sciences|January 15, 2013
KIDs rule: regulatory phosphorylation of RTKsLauren E Locascio, Daniel J DonoghueProgress in Cell Cycle Research|November 5, 2003
Cyclin B1 and CDK1: nuclear localization and upstream regulatorsLisa A Porter, Daniel J DonoghueThe Journal of Biological Chemistry|February 6, 2002
Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activationMonica Kong, Ching S Wang, Daniel J DonoghueCytokine & Growth Factor Reviews|January 4, 2020
Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinomaFangda Li, Malalage N Peiris, Daniel J DonoghueOncotarget|May 21, 2019
BCR: a promiscuous fusion partner in hematopoietic disordersMalalage N Peiris, Fangda Li, Daniel J DonoghueOncogene|December 14, 2004
Constitutive activation of the shh-ptc1 pathway by a patched1 mutation identified in BCCElizabeth A Barnes, Keely J Heidtman, Daniel J DonoghueCell Cycle (Georgetown, Tex.)|December 25, 2008
The atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is dependent upon p53 to inhibit apoptosisChristopher W McAndrew, Randy F Gastwirt, Daniel J DonoghueMolecular Biology of the Cell|September 16, 2003
Spy1 interacts with p27Kip1 to allow G1/S progressionLisa A Porter, Monica Kong-Beltran, Daniel J DonoghueCell Cycle (Georgetown, Tex.)|May 18, 2007
Speedy/RINGO regulation of CDKs in cell cycle, checkpoint activation and apoptosisRandy F Gastwirt, Christopher W McAndrew, Daniel J DonoghueCancer Research|September 17, 2008
Nordihydroguaiaretic acid inhibits an activated fibroblast growth factor receptor 3 mutant and blocks downstream signaling in multiple myeloma cellsApril N Meyer, Christopher W McAndrew, Daniel J DonoghuePageof 5